| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |